Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:item
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:adrenal_cortical_carcinoma
|
| gptkbp:acquired |
Oral sodium loading test
Saline infusion test |
| gptkbp:affects |
Adults
|
| gptkbp:associated_with |
Adrenal adenoma
Adrenal hyperplasia |
| gptkbp:can_lead_to |
Kidney damage
Cardiovascular complications |
| gptkbp:caused_by |
Fatigue
Muscle weakness Headaches Metabolic alkalosis Primary hyperaldosteronism |
| gptkbp:current_use |
Affects quality of life
Can be life-threatening if untreated Can lead to chronic health issues May require lifelong management Requires medical attention |
| gptkbp:descendant |
gptkb:battle
|
| gptkbp:discovered_by |
Dr. Jerome Conn
|
| gptkbp:first_described_by |
gptkb:1955
|
| https://www.w3.org/2000/01/rdf-schema#label |
Conn's syndrome
|
| gptkbp:is_affected_by |
Obesity
High salt intake |
| gptkbp:is_associated_with |
Increased risk of heart attack
Increased risk of stroke |
| gptkbp:is_characterized_by |
High blood pressure
Low potassium levels |
| gptkbp:is_monitored_by |
Blood pressure checks
Regular blood tests |
| gptkbp:is_often_used_in |
gptkb:philosopher
|
| gptkbp:is_part_of |
Endocrine hypertension syndromes
|
| gptkbp:is_popular_in |
1-2% of hypertensive patients
|
| gptkbp:is_related_to |
Excess aldosterone production
|
| gptkbp:is_used_for |
Numbness
Palpitations Tingling sensations |
| gptkbp:requires |
Laparoscopic adrenalectomy
|
| gptkbp:resulted_in |
Adrenal gland tumors
Hyperplasia of adrenal cortex |
| gptkbp:scientific_classification |
Secondary hypertension
|
| gptkbp:social_responsibility |
CT scan of adrenal glands
Essential hypertension Plasma aldosterone concentration Plasma renin activity |
| gptkbp:symptoms |
Hypertension
Hypokalemia |
| gptkbp:treatment |
gptkb:hospital
Endocrinologists Spironolactone Aldosterone antagonists Eplerenone |